L-arginine
Also called: arginine
L-arginine is an amino acid found in many protein-containing foods, especially animal products and nuts; typical dietary intake is 4–5 g/day. The body also makes arginine, mainly in the kidneys, from citrulline.
- Category
- Amino acid and protein
- Forms
- L-arginine; Health Canada also lists L-arginine monohydrochloride, L-arginine alpha-ketoglutarate, L-arginine ketoisocaproic acid and DL-arginine as source ingredients (oral, synthetic)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2022 meta-analysis (Advances in Nutrition) included 22 RCTs of oral L-arginine versus placebo in adults, for blood pressure; infusion and acute studies were excluded. [4]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels3 topics
CMuscles and exercise1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in adults | B | A 2022 meta-analysis of 22 RCTs (30 effect sizes) of oral L-arginine found lower systolic (−6.40 mmHg) and diastolic (−2.64 mmHg) pressure than placebo; no significant change was seen at doses above 9 g/day. [4] |
| 24-hour ambulatory blood pressure | B | A 2026 meta-analysis of 5 RCTs (202 participants) reported lower 24-hour systolic (−4.23 mmHg) and diastolic (−3.04 mmHg) pressure with oral L-arginine; the authors note the number of included studies was limited. [5] |
| Vascular stiffness and heart function after acute myocardial infarction | X | In the VINTAGE MI trial (153 patients, 6 months), L-arginine added to standard care did not improve vascular stiffness or ejection fraction; 6 patients (8.6%) on L-arginine died versus none on placebo. [6] |
| Athletic performance | C | ODS calls the evidence limited and conflicting: 2–20 g/day appears to have little to no effect on aerobic or anaerobic performance, and a review of 54 mostly small studies found little or no enhancement. [1] |
Main constituents: L-arginine, which can be converted to nitric oxide (a blood-vessel dilator) and is a precursor for creatine [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Blood-pressure trials gave oral L-arginine for at least 4 days; the dose-response analysis detected an effect on systolic pressure at 4 g/day or more (2022 meta-analysis). [4]
- VINTAGE MI: goal dose of 3 g three times a day for 6 months after a first ST-segment elevation myocardial infarction. [6]
- Exercise studies described by ODS used 2–20 g/day; most lasted 4–8 weeks. [1]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingHealth Canada's L-arginine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Blood pressure medicines (antihypertensives); Medicines for cardiovascular disease or erectile dysfunction, and blood thinners
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications6 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada NNHPD L-arginine monograph (July 25, 2025), adults 18 years and older: 0.21–21 g/day for protein synthesis, or 6–21 g/day for exercise …
Details and sources
- After a heart attack: in VINTAGE MI, deaths were higher with L-arginine (6 vs 0, P = .01), the safety monitoring committee closed enrollment, and the authors concluded L-arginine should not be recommended following acute myocardial infarction. [6]
- MSK warns that arginine may increase risk of mortality in people who have had an acute myocardial infarction, and that long-term use may worsen peripheral artery disease. [2]
- Health Canada's monograph states, for products providing more than 9 g/day: "Do not use if you have had a heart attack/myocardial infarction." [3]
- ODS: up to 9 g/day for several days or weeks appears safe and well tolerated; at 9–30 g/day the most common reactions are gastrointestinal (such as diarrhea and nausea) and slightly lower blood pressure. The safety of high-dose use for more than 3 months is not known. [1]
- MSK lists abdominal pain, bloating, nausea and diarrhea as adverse reactions, and notes that limited studies suggest arginine may increase breast tumor growth; more research is needed. [2]
- Health Canada requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [3]
Interactions
| With | What happens |
|---|---|
| Blood pressure medicines (antihypertensives) | MSK states arginine could temporarily lower blood pressure in patients with diabetes and may have additive hypotensive effects. [2] |
| Medicines for cardiovascular disease or erectile dysfunction, and blood thinners | Health Canada requires a caution (above 0.42 g/day) to ask a health care practitioner before use if taking these medicines. [3] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- MSK notes that some protein powders or products claiming to improve sports performance may contain arginine. [2]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
- Canada: Health Canada's L-arginine monograph (oral) includes the use "May help support a modest improvement in exercise capacity in individuals with stable cardiovascular diseases (CVD)." [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- L-arginine (proper name (S)-2-Amino-5-[(aminoiminomethyl) amino] pentanoic acid); synthetic preparation Amino acid [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 6 entries naming L-arginine as part of a salt, complex or mixture (for example L-arginine alpha ketoglutarate (2:1) and arginine silicate inositol complex); none names L-arginine alone (earliest NDI 230 submitted 2003-05-05; most recent NDI 786 submitted 2013-01-10). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Blood pressure medicines (antihypertensives): MSK states arginine could temporarily lower blood pressure in patients with diabetes and may have additive hypotensive effects. [P6]
- Medicines for cardiovascular disease or erectile dysfunction, and blood thinners: Health Canada requires a caution (above 0.42 g/day) to ask a health care practitioner before use if taking these medicines. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P4]
Supply and conservation
- Health Canada's monograph lists the preparation of L-arginine as synthetic. [P5]
Absorption in people
- ODS states citrulline may raise blood arginine levels more efficiently than arginine itself, because more citrulline is absorbed from the gut. [P7]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada NNHPD L-arginine monograph (July 25, 2025), adults 18 years and older: 0.21–21 g/day for protein synthesis, or 6–21 g/day for exercise capacity in stable cardiovascular disease, not exceeding 8 g per single dose; duration statements apply at 3 g/day or more. [P5]
Pregnancy and breastfeeding
- Health Canada's L-arginine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [P5]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports index (TR-000 to TR-606, checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- Health Canada, NNHPD. Monograph: L-Arginine (monograph date July 25, 2025 as printed), 2025-07-25. webprod.hc-sc.gc.ca
- Memorial Sloan Kettering Cancer Center. About Herbs: Arginine (Last Updated February 10, 2022), 2022-02-10. mskcc.org
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
Sources
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Arginine (Last Updated February 10, 2022), 2022-02-10. mskcc.org
- Health Canada, NNHPD. Monograph: L-Arginine (monograph date July 25, 2025 as printed), 2025-07-25. webprod.hc-sc.gc.ca
- Shiraseb F, et al. Effect of l-arginine supplementation on blood pressure in adults: a systematic review and dose-response meta-analysis of randomized clinical trials. Adv Nutr 2022;13(4):1226-1242 (PMID 34967840), 2022-08-01. pubmed.ncbi.nlm.nih.gov
- Shi Y, et al. Reassessment of the effect of oral l-arginine on blood pressure: a systematic review and meta-analysis based on ambulatory blood pressure monitoring. Nitric Oxide 2026;164:60-68 (PMID 42520885), 2026-10. pubmed.ncbi.nlm.nih.gov
- Schulman SP, et al. L-arginine therapy in acute myocardial infarction: the VINTAGE MI randomized clinical trial. JAMA 2006;295(1):58-64 (PMID 16391217), 2006-01-04. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.